Preparation and characterization of tadalafil-loaded hydrogel: An in-vivo evaluation of wound healing activity
Anita Sadat Haji Seyed Javadi Pajouhi , Amir Larki-Harcheghani , Mojdeh Mohammadi , Sajjad Makhdoomi , Alireza Nourian , Katayoun Derakhshandeh
Pharmaceutical Science Advances ›› 2025, Vol. 3 ›› Issue (1) : 100066
Preparation and characterization of tadalafil-loaded hydrogel: An in-vivo evaluation of wound healing activity
Tadalafil (TD) is a phosphodiesterase type 5 (PDE-5) inhibitor that has gained attention for its wound healing properties. In this study, a TD-loaded hydrogel was prepared and characterized, and its wound-healing efficacy was evaluated. After preparing the TD hydrogel, its physicochemical properties such as viscosity, pH, drugloading capacity (DL%), in vitro release behavior, and stability were characterized. Moreover, in vivo studies were performed to evaluate hydroxyproline (HP) and the wound healing efficacy of 1,1.5,3\%(w/w) TD hydrogels in New Zealand rabbits. Histopathological analysis was also performed using hematoxylin and eosin (H&E) staining. We successfully prepared a TD hydrogel with high stability. The results of the in vivo experiments on full-thickness wounds showed that the 1.5%TD hydrogel with a pH of 5.81±0.421, viscosity of 12,435±63, drug-loading capacity of 91.73±1.482%, and drug release rate of 88% was superior to other formulations when HP level was increased, which decreased the time required for wound healing; this was corroborated by the histological analysis. Thus, the TD hydrogel formulation prepared in this study is a promising topical therapeutic agent for wound healing.
Tadalafil / Hydrogel / Wound healing / Hydroxyproline / Phosphodiesterase type 5 inhibitor
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
/
| 〈 |
|
〉 |